Endo
FDA makes unprecedented move, asks Endo to pull painkiller from market
Richard Staines
Endo, fda, opioid epidemic, pain, regulation, safety
0 Comment
Regulator concerned about potential abuse of Opana ER
X
FDA makes unprecedented move, asks Endo to pull painkiller from market
https://pharmaphorum.com/news/fda-asks-endo-pull-painkiller-market/
X
Risks of Endo painkiller outweigh benefits, say FDA advisers
https://pharmaphorum.com/news/risks-endo-painkiller-outweigh-benefits-say-fda-advisers/
FDA delays decision on abuse deterrence data on Endo painkiller
Richard Staines
abuse, Endo, generic, opioid, pain, Purdue
0 Comment
Data could be used to fend off generic competition.
X
FDA delays decision on abuse deterrence data on Endo painkiller
https://pharmaphorum.com/news/fda-delays-decision-on-key-abuse-deterrence-data-on-endo-painkiller/